Long
ASXC FDA approval sell the leap options
ASXC has FDA approval for the surgical device granted this month.
ASXC has adequate cash for two year burn as sales are ramped up.
Sell the ASXC Jan 2023 leap options and the raw cost is $2 per share. Stock is as of today $3.80 range.
Invest the cash in GGN and trade GGN monthly into the dividend ex-date.
own the stock for nearly free at any cost in 21 months.
good product
small cap with adequate share count and volume.
reasonable speculation
see the links below...
all the best.
ASXC has adequate cash for two year burn as sales are ramped up.
Sell the ASXC Jan 2023 leap options and the raw cost is $2 per share. Stock is as of today $3.80 range.
Invest the cash in GGN and trade GGN monthly into the dividend ex-date.
own the stock for nearly free at any cost in 21 months.
good product
small cap with adequate share count and volume.
reasonable speculation
see the links below...
all the best.
Note
GGN up today with 2 weeks to monthly distribution dates. Sold mine today...
not an April Fools day joke...
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.